We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Lesaka Technologies
LSAK
$388M
| $395K | ﹤0.01% |
21,602
+10
| +0% | +$151 |
|
|
EXL
2027
DELISTED
EXCEL TRUST , INC COM STK
EXL
| $389K | ﹤0.01% |
24,658
-6,135
| -20% | -$96.3K |
|
2028
Customers Bancorp
CUBI
$2.59B
| $388K | ﹤0.01% |
14,428
+151
| +1% | +$3.86K |
|
|
TOWR
2029
DELISTED
Tower International, Inc.
TOWR
| $388K | ﹤0.01% |
14,876
+4,119
| +38% | +$113K |
|
|
CBF
2030
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $377K | ﹤0.01% |
12,965
-106
| -0.8% | -$3.02K |
|
2031
Ingles Markets
IMKTA
$1.63B
| $376K | ﹤0.01% |
7,880
+2,209
| +39% | +$107K |
|
|
REMY
2032
DELISTED
REMY INTL INC NEW COMMON
REMY
| $370K | ﹤0.01% |
16,715
-90
| -0.5% | -$2.01K |
|
2033
Walker & Dunlop
WD
$1.65B
| $369K | ﹤0.01% |
13,818
-699
| -5% | -$15.5K |
|
|
JPS
2034
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
| $369K | ﹤0.01% |
43,567
+1,755
| +4% | +$15.7K |
|
2035
Coca-Cola Consolidated
COKE
$12.3B
| $364K | ﹤0.01% |
24,100
+120
| +0.5% | +$1.44K |
|
2036
Towne Bank
TOWN
$3.35B
| $361K | ﹤0.01% |
22,181
-3,466
| -14% | -$56.3K |
|
|
SFR
2037
DELISTED
Starwood Waypoint Homes
SFR
| $357K | ﹤0.01% |
15,031
-968
| -6% | -$24.8K |
|
2038
ICF International
ICFI
$1.44B
| $354K | ﹤0.01% |
10,169
+56
| +0.6% | +$2.11K |
|
2039
US Physical Therapy
USPH
$1.14B
| $352K | ﹤0.01% |
6,430
+70
| +1% | +$3.47K |
|
|
FRED
2040
DELISTED
Fred's Inc
FRED
| $349K | ﹤0.01% |
18,114
+142
| +0.8% | +$2.53K |
|
|
SNR
2041
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $347K | ﹤0.01% |
25,923
-2,138
| -8% | -$33.9K |
|
|
COWN
2042
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $345K | ﹤0.01% |
13,473
+6
| +0% | +$141 |
|
|
CSR
2043
Centerspace
CSR
$936M
| $344K | ﹤0.01% |
4,819
-1,304
| -21% | -$94.4K |
|
|
TGB
2044
Trekor Metals
TGB
$2.56B
| $342K | ﹤0.01% |
618,076
-11,398
| -2% | -$8.02K |
|
2045
Usana Health Sciences
USNA
$394M
| $341K | ﹤0.01% |
4,994
-172
| -3% | -$10.9K |
|
2046
Celestica
CLS
$35.1B
| $340K | ﹤0.01% |
29,220
-1,808
| -6% | -$22K |
|
|
METR
2047
DELISTED
METRO BANCORP, INC COMMON STOCK
METR
| $336K | ﹤0.01% |
12,872
-41
| -0.3% | -$1.07K |
|
|
FDML
2048
DELISTED
Federal-Mogul Holdings Corporation
FDML
| $335K | ﹤0.01% |
29,551
+11,396
| +63% | +$145K |
|
2049
ATI
ATI
$27B
| $334K | ﹤0.01% |
11,056
+2,103
| +23% | +$69.5K |
|
|
AXIA
2050
AXIA Energia
AXIA
$22.6B
| $332K | ﹤0.01% |
222,694
+51,841
| +30% | +$89.7K |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.